175 related articles for article (PubMed ID: 24246525)
21. Combined hormonal contraception and migraine: are we being too strict?
Voedisch AJ; Hindiyeh N
Curr Opin Obstet Gynecol; 2019 Dec; 31(6):452-458. PubMed ID: 31573998
[TBL] [Abstract][Full Text] [Related]
22. [Hormonal contraception and vascular risk].
Plu-Bureau G; Hugon-Rodin J; Raccah-Tebeka B
Rev Prat; 2018 Apr; 68(4):394-400. PubMed ID: 30869386
[TBL] [Abstract][Full Text] [Related]
23. Combined hormonal contraceptive (CHC) use among obese women and contraceptive effectiveness: a systematic review.
Dragoman MV; Simmons KB; Paulen ME; Curtis KM
Contraception; 2017 Feb; 95(2):117-129. PubMed ID: 27823942
[TBL] [Abstract][Full Text] [Related]
24. [Choosing contraception for adolescents].
Wemeau-jacquemont C
NPN Med; 1985 Feb; 5(84):185-9. PubMed ID: 12280585
[TBL] [Abstract][Full Text] [Related]
25. Trends in contraceptive use according to HIV status among privately insured women in the United States.
Haddad LB; Monsour M; Tepper NK; Whiteman MK; Kourtis AP; Jamieson DJ
Am J Obstet Gynecol; 2017 Dec; 217(6):676.e1-676.e11. PubMed ID: 28866122
[TBL] [Abstract][Full Text] [Related]
26. Oral contraceptives.
Maclennan AH
Curr Ther (Seaforth); 1987 Dec; 28(12):113-22. PubMed ID: 12317413
[TBL] [Abstract][Full Text] [Related]
27. Risk of thromboembolism in patients with COVID-19 who are using hormonal contraception.
Cohen MA; Edelman A; Paynter R; Henderson JT
Cochrane Database Syst Rev; 2023 Jan; 1(1):CD014908. PubMed ID: 36622724
[TBL] [Abstract][Full Text] [Related]
28. Oral contraception and venous thromboembolism. A New Zealand perspective.
Roke C
Drug Saf; 1997 Feb; 16(2):79-87. PubMed ID: 9067120
[TBL] [Abstract][Full Text] [Related]
29. Type of Combined Contraceptives, Factor V Leiden Mutation and Risk of Venous Thromboembolism.
Hugon-Rodin J; Horellou MH; Conard J; Gompel A; Plu-Bureau G
Thromb Haemost; 2018 May; 118(5):922-928. PubMed ID: 29614525
[TBL] [Abstract][Full Text] [Related]
30. Oral combined hormonal contraceptive associated with protection against allodynia in migraine in a cross-sectional study.
Vitali-Silva A; Vuolo IG; Gonzalez LH; Galvão RF; Farges SG; Bello VA; Poli-Frederico RC
Ir J Med Sci; 2023 Oct; 192(5):2203-2208. PubMed ID: 36720786
[TBL] [Abstract][Full Text] [Related]
31. Risks and benefits of oral contraceptive use in women over 35.
Cramer DW; Cann CI
Maturitas; 1988; Suppl 1():99-109. PubMed ID: 3237116
[TBL] [Abstract][Full Text] [Related]
32. Inappropriate use of combined hormonal contraceptives for birth control among women of reproductive age in the United States.
Yu J; Hu XH
J Womens Health (Larchmt); 2013 Jul; 22(7):595-603. PubMed ID: 23789583
[TBL] [Abstract][Full Text] [Related]
33. [Hormonal contraception].
Van Cauwenberge JR
Rev Med Liege; 1992 May; 47(5):221-36. PubMed ID: 1604074
[TBL] [Abstract][Full Text] [Related]
34. Breast cancer among young U.S. women in relation to oral contraceptive use.
White E; Malone KE; Weiss NS; Daling JR
J Natl Cancer Inst; 1994 Apr; 86(7):505-14. PubMed ID: 8133534
[TBL] [Abstract][Full Text] [Related]
35. Contraindications to progestin-only oral contraceptive pills among reproductive-aged women.
White K; Potter JE; Hopkins K; Fernández L; Amastae J; Grossman D
Contraception; 2012 Sep; 86(3):199-203. PubMed ID: 22364816
[TBL] [Abstract][Full Text] [Related]
36. [The CHOICE study (Contraceptive Health Research Of Informed Choice Experience)--an educational research program for Polish women planning combined hormonal contraceptives use].
Tomaszewski J; Paszkowski T; Debski R; Kotarski J; Skrzypulec-Plinta V; Spaczyński RZ; Pawelczyk L
Ginekol Pol; 2012 Jun; 83(6):417-23. PubMed ID: 22880460
[TBL] [Abstract][Full Text] [Related]
37. Smoking and use of oral contraceptives: impact on thrombotic diseases.
Lidegaard O
Am J Obstet Gynecol; 1999 Jun; 180(6 Pt 2):S357-63. PubMed ID: 10368521
[TBL] [Abstract][Full Text] [Related]
38. Combined Hormonal Contraceptives and First Venous Thrombosis in Young French Women: Impact of Thrombotic Family History.
Hugon-Rodin J; Horellou MH; Conard J; Gompel A; Plu-Bureau G
J Endocr Soc; 2017 Jun; 1(6):762-771. PubMed ID: 29264528
[TBL] [Abstract][Full Text] [Related]
39. Contraceptive Preference, Continuation Rates, and Unintended Pregnancies in Patients with Comorbidities: A Prospective Cohort Study.
Leroy-Melamed M; Zhao Q; Belmonte MA; Archer J; Peipert JF
J Womens Health (Larchmt); 2021 Oct; 30(10):1469-1475. PubMed ID: 33404367
[No Abstract] [Full Text] [Related]
40. Long-acting reversible contraceptive acceptability and unintended pregnancy among women presenting for short-acting methods: a randomized patient preference trial.
Hubacher D; Spector H; Monteith C; Chen PL; Hart C
Am J Obstet Gynecol; 2017 Feb; 216(2):101-109. PubMed ID: 27662799
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
